The Biotech Division of Microprofit Group was established in 1996 and officially registered as Shenzhen Microprofit Biotech Co., Ltd. in 2009. Since its inception, the company has upheld the philosophy of “Continuous Innovation, Pursuit of Excellence,” dedicating itself to safeguarding human health and sustaining life through technological innovation, and is recognized as a National High-Tech Enterprise and a Shenzhen “Specialized, Refined, and New” Enterprise.

fluorecare® is Microprofit’s flagship brand, representing the company’s commitment to high-quality diagnostic innovation. Under the fluorecare® brand, Microprofit provides a comprehensive range of rapid test solutions and intelligent POCT (Point-of-Care Testing) systems that combine precision, reliability, and user-friendly design — serving healthcare professionals and patients worldwide.

Microprofit has deeply cultivated its presence across in vitro diagnostics (IVD), intelligent medical devices, biological raw materials, and cell science, establishing four core R&D systems — the Reagent Platform, Equipment Platform, Raw Material Platform, and Cell Platform — and realizing a full industrial chain product layout from raw material development to intelligent diagnostics.